Bictegravir and its Impurities

Bictegravir (INN, BIC, formerly known as GS-9883) is an antiviral drug of the integrase inhibitor class that was structurally derived from an earlier compound dolutegravir by scientists at Gilead Sciences. Reference standards of Bictegravir API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 23 results for Bictegravir Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911000

(S)-3,9-Dihydroxy-2-((1S,3R)-3-hydroxycyclopentyl)-1,8-dioxo-N-(2,4,6-trifluorobenzyl)-1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide

(S)-3,9-Dihydroxy-2-((1S,3R)-3-hydroxycyclopentyl)-1,8-dioxo-N-(2,4,6-trifluorobenzyl)-1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide

  • Catalogue No.:PA 02 1911000

  • CAS :

    NA

  • Molecular Formula : C21H20F3N3O6

  • Molecular Weight : 467.4

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911001

(R)-3,9-Dihydroxy-2-((1S,3R)-3-hydroxycyclopentyl)-1,8-dioxo-N-(2,4,6-trifluorobenzyl)-1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide

(R)-3,9-Dihydroxy-2-((1S,3R)-3-hydroxycyclopentyl)-1,8-dioxo-N-(2,4,6-trifluorobenzyl)-1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide

  • Catalogue No.:PA 02 1911001

  • CAS :

    NA

  • Molecular Formula : C21H20F3N3O6

  • Molecular Weight : 467.4

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911002

(2R,5S)-8-Hydroxy-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine 6,12-dioxide

(2R,5S)-8-Hydroxy-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine 6,12-dioxide

  • Catalogue No.:PA 02 1911002

  • CAS :

    NA

  • Molecular Formula : C21H18F3N3O7

  • Molecular Weight : 481.38

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1910000

Bictegravir

Bictegravir

  • Catalogue No.:PA 02 1910000

  • CAS :

    1611493-60-7

  • Molecular Formula : C21H18F3N3O5

  • Molecular Weight : 449.39

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911003

(2S,5R,13aS)-8-Hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

(2S,5R,13aS)-8-Hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

  • Catalogue No.:PA 02 1911003

  • CAS :

    1616340-12-5

  • Molecular Formula : C21H18F3N3O5

  • Molecular Weight : 449.39

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911004

(2R,5R,13aR)-8-Hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

(2R,5R,13aR)-8-Hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

  • Catalogue No.:PA 02 1911004

  • CAS :

    1846582-14-6

  • Molecular Formula : C21H18F3N3O5

  • Molecular Weight : 449.39

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911005

(2R,5S,13aR)-8-Methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

(2R,5S,13aR)-8-Methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

  • Catalogue No.:PA 02 1911005

  • CAS :

    1616340-94-3

  • Molecular Formula : C22H20F3N3O5

  • Molecular Weight : 463.41

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911006

(2R,5S,13aR)-N-(2,4-Difluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

(2R,5S,13aR)-N-(2,4-Difluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

  • Catalogue No.:PA 02 1911006

  • CAS :

    1611493-56-1

  • Molecular Formula : C21H19F2N3O5

  • Molecular Weight : 431.4

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911007

(2S,5R,13aS)-N-(2-Fluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

(2S,5R,13aS)-N-(2-Fluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

  • Catalogue No.:PA 02 1911007

  • CAS :

    1616339-90-2

  • Molecular Formula : C21H20FN3O5

  • Molecular Weight : 413.41

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911008

(2S,5R,13aS)-N-(4-Fluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

(2S,5R,13aS)-N-(4-Fluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

  • Catalogue No.:PA 02 1911008

  • CAS :

    1616339-82-2

  • Molecular Formula : C21H20FN3O5

  • Molecular Weight : 413.41

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911009

(2S,5R,13aS)-N-(2,6-Difluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

(2S,5R,13aS)-N-(2,6-Difluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

  • Catalogue No.:PA 02 1911009

  • CAS :

    1616340-13-6

  • Molecular Formula : C21H19F2N3O5

  • Molecular Weight : 431.4

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911010

1-(2,2-Dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid

1-(2,2-Dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid

  • Catalogue No.:PA 02 1911010

  • CAS :

    1335210-23-5

  • Molecular Formula : C13H17NO8

  • Molecular Weight : 315.28

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911011

(2S,3S,4S,5R,6S)-6-(((2R,5S,13aR)-7,9-Dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid

(2S,3S,4S,5R,6S)-6-(((2R,5S,13aR)-7,9-Dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid

  • Catalogue No.:PA 02 1911011

  • CAS :

    2365156-60-9

  • Molecular Formula : C27H26F3N3O11

  • Molecular Weight : 625.51

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA STI 089238

Bictegravir-13C-15N-d2

Bictegravir-13C-15N-d2

  • Catalogue No.:PA STI 089238

  • CAS :

    NA

  • Molecular Formula : C2013CH16D2F3N215NO5

  • Molecular Weight : 453.38

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911012

9-Hydroxy-2-((1S,3R)-3-hydroxycyclopentyl)-1,8-dioxo-N-(2,4,6-trifluorobenzyl)-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide

9-Hydroxy-2-((1S,3R)-3-hydroxycyclopentyl)-1,8-dioxo-N-(2,4,6-trifluorobenzyl)-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide

  • Catalogue No.:PA 02 1911012

  • CAS :

    NA

  • Molecular Formula : C21H18F3N3O5

  • Molecular Weight : 449.39

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911013

(2R,5S,13aR)-8-Hydroxy-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine 6,12-dioxide

(2R,5S,13aR)-8-Hydroxy-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine 6,12-dioxide

  • Catalogue No.:PA 02 1911013

  • CAS :

    NA

  • Molecular Formula : C21H18F3N3O7

  • Molecular Weight : 481.38

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA STI 089828

Bictegravir D4

Bictegravir D4

  • Catalogue No.:PA STI 089828

  • CAS :

    2714436-47-0

  • Molecular Formula : C21H14D4F3N3O5

  • Molecular Weight : 453.41

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911014

(2R,5S,13aR)-N-(2,4-Difluoro-6-(nitroso(2,4,6-trifluorobenzyl)amino)benzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

(2R,5S,13aR)-N-(2,4-Difluoro-6-(nitroso(2,4,6-trifluorobenzyl)amino)benzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

  • Catalogue No.:PA 02 1911014

  • CAS :

    NA

  • Molecular Formula : C28H22F5N5O6

  • Molecular Weight : 619.51

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911015

(1R,4S)-2-Oxa-3-azabicyclo[2.2.1]heptane Hydrochloride

(1R,4S)-2-Oxa-3-azabicyclo[2.2.1]heptane Hydrochloride

  • Catalogue No.:PA 02 1911015

  • CAS :

    2411506-37-9

  • Molecular Formula : C5H10ClNO

  • Molecular Weight : 135.59

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911016

(R)-1-((1R,4S)-2-Oxa-3-azabicyclo[2.2.1]heptan-3-yl)-2-hydroxy-2-phenylethan-1-one

(R)-1-((1R,4S)-2-Oxa-3-azabicyclo[2.2.1]heptan-3-yl)-2-hydroxy-2-phenylethan-1-one

  • Catalogue No.:PA 02 1911016

  • CAS :

    2411506-35-7

  • Molecular Formula : C13H15NO3

  • Molecular Weight : 233.27

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911017

(2R,5S,13aR)-8-Methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic Acid

(2R,5S,13aR)-8-Methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic Acid

  • Catalogue No.:PA 02 1911017

  • CAS :

    1616342-45-0

  • Molecular Formula : C15H16N2O6

  • Molecular Weight : 320.30

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911018

(2R,5S,13aS)-8-Hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

(2R,5S,13aS)-8-Hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

  • Catalogue No.:PA 02 1911018

  • CAS :

    NA

  • Molecular Formula : C21H18F3N3O5

  • Molecular Weight : 449.39

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 02 1911019

1-(2,2-Dihydroxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid

1-(2,2-Dihydroxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid

  • Catalogue No.:PA 02 1911019

  • CAS :

    1616340-75-0

  • Molecular Formula : C11H13NO8

  • Molecular Weight : 287.22

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
pharmaffiliates